Journal: Journal of Pharmacy & Bioallied Sciences

Article Title: Preparation and in vitro/in vivo characterization of curcumin microspheres intended to treat colon cancer

doi: 10.4103/0975-7406.94825

Figure Lengend Snippet: Percent cumulative in vitro drug release profile of curcumin from Eudragit microspheres containing different drug-polymer ratios and plain curcumin drug in simulated gastrointestinal transit conditions i.e., at pH 1.2 for first 2 h, pH 4.5 for 2-4 h and at pH 7.0 for 4- 24 h

Article Snippet: Eudragit S100 was procured as a gift sample from MSN Laboratories Ltd, Hyderabad, India.

Techniques: In Vitro, Polymer

Journal: Journal of Pharmacy & Bioallied Sciences

Article Title: Preparation and in vitro/in vivo characterization of curcumin microspheres intended to treat colon cancer

doi: 10.4103/0975-7406.94825

Figure Lengend Snippet: Curcumin content in isolated organs of albino rats after oral administration of curcumin loaded Eudragit microspheres and plain curcumin

Article Snippet: Eudragit S100 was procured as a gift sample from MSN Laboratories Ltd, Hyderabad, India.

Techniques: Isolation

Journal: Molecular Metabolism

Article Title: Intermittent rapamycin feeding recapitulates some effects of continuous treatment while maintaining lifespan extension

doi: 10.1016/j.molmet.2024.101902

Figure Lengend Snippet: Detailed numbers of mice per experimental group as well as time of testing and treatment start. Controls were fed with normal chow containing Eudragit S100 encapsulation material (0.48 g/kg diet). Mice on the intermittent feeding schedule were fed Rapamycin (42 mg/kg diet) one week then one week of normal chow containing Eudragit S100 encapsulation material (0.48 g/kg diet). The continuous feeding group was fed Rapamycin (42 mg/kg diet) continuously throughout the experiment.

Article Snippet: Eudragit S100 (0.48 g/kg diet) , ssniff Spezialdiäten GmbH , S9159-S712.

Techniques: Encapsulation, Control

Journal: Molecular Metabolism

Article Title: Intermittent rapamycin feeding recapitulates some effects of continuous treatment while maintaining lifespan extension

doi: 10.1016/j.molmet.2024.101902

Figure Lengend Snippet:

Article Snippet: Eudragit S100 (0.48 g/kg diet) , ssniff Spezialdiäten GmbH , S9159-S712.

Techniques: Recombinant, Software

Journal: Polymers

Article Title: Fabrication of Tizanidine Loaded Patches Using Flaxseed Oil and Coriander Oil as a Penetration Enhancer for Transdermal Delivery

doi: 10.3390/polym13234217

Figure Lengend Snippet: DSC thermograms of tizanidine with physical mixtures of chitosan and thiolated chitosan (A), EC and PVP (B), and Eudragit RL100 and PVP (C).

Article Snippet: Eudragit RL100, ethyl cellulose (99%), polyvinyl alcohol-1750 (PVA1750), polyvinyl pyrrolidone-K30 (PVAK30), low average molecular weight chitosan (100,000 g/mol) with degree of deacetylation (75–85%) and viscosity of 20–300 cP and di-n-butylphthalate were purchased from Sigma-Aldrich (Sigma-Aldrich Chemie GmbH.

Techniques:

Journal: Polymers

Article Title: Fabrication of Tizanidine Loaded Patches Using Flaxseed Oil and Coriander Oil as a Penetration Enhancer for Transdermal Delivery

doi: 10.3390/polym13234217

Figure Lengend Snippet: FT-IR spectra of flaxseed oil (a); coriander oil (b); tizanidine (c); chitosan, thiolated chitosan, and tizanidine mixture (d); Eudragit RL100, PVP, and tizanidine mixture (e); PVP, flaxseed/coriander oil, and tizanidine mixture (f); and PVP, Eudragit RL100, flaxseed/coriander oil, and tizanidine mixture (g).

Article Snippet: Eudragit RL100, ethyl cellulose (99%), polyvinyl alcohol-1750 (PVA1750), polyvinyl pyrrolidone-K30 (PVAK30), low average molecular weight chitosan (100,000 g/mol) with degree of deacetylation (75–85%) and viscosity of 20–300 cP and di-n-butylphthalate were purchased from Sigma-Aldrich (Sigma-Aldrich Chemie GmbH.

Techniques:

Journal: Polymers

Article Title: Fabrication of Tizanidine Loaded Patches Using Flaxseed Oil and Coriander Oil as a Penetration Enhancer for Transdermal Delivery

doi: 10.3390/polym13234217

Figure Lengend Snippet: ( A ) in vitro drug release of tizanidine from polymers chitosan/thiolated chitosan, EC/PVP/flaxseed oil, EC/PVP/coriander oil, Eudragit RL100/PVP/flaxseed oil, Eudragit RL100/PVP/coriander oil and ( B ) in vitro drug release of FTZNE23, FTZNE36 and FTZNE54, n = 3, mean ± S.D.

Article Snippet: Eudragit RL100, ethyl cellulose (99%), polyvinyl alcohol-1750 (PVA1750), polyvinyl pyrrolidone-K30 (PVAK30), low average molecular weight chitosan (100,000 g/mol) with degree of deacetylation (75–85%) and viscosity of 20–300 cP and di-n-butylphthalate were purchased from Sigma-Aldrich (Sigma-Aldrich Chemie GmbH.

Techniques: In Vitro

Journal: Drug Delivery

Article Title: pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms

doi: 10.1080/10717544.2017.1279238

Figure Lengend Snippet: Categories of pH responsive nanoparticles with example materials and applications for oral drug delivery.

Article Snippet: CyA , Nanoporous silica (Sylysia 350) and Eudragit® S100 nanomatrix , 90.8% vs. Neoral , Rats , Dai et al. ( ) .

Techniques: In Vitro

Journal: Drug Delivery

Article Title: pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms

doi: 10.1080/10717544.2017.1279238

Figure Lengend Snippet: Examples of relative bioavailability improvement of insulin and CyA after oral administration of different pH-responsive carrier.

Article Snippet: CyA , Nanoporous silica (Sylysia 350) and Eudragit® S100 nanomatrix , 90.8% vs. Neoral , Rats , Dai et al. ( ) .

Techniques: Injection, Capsules